Japan, Sept. 3 -- IMMUNITYBIO INC has got intellectual property rights for 'ELIMINATION OF PD-L1-POSITIVE MALIGNANCIES BY PD-L1 CHIMERIC ANTIGEN RECEPTOR-EXPRESSING NK CELLS.' Other related details are as follows:

Application Number: JP,2025-034787

Category (FI): A61K40/31,A61K39/395@N,A61K39/395@D,C12N15/63@Z,C12N5/10,A61K40/15,C12N15/24,C12N15/13,C12N15/11@Z,A61P43/00,121,A61P35/02,C12N15/26,C12N15/62@Z,A61K35/17,A61P35/00

Stage: Grant (IP right granted following substantive examination.)

Filing Date: March 5, 2025

Publication Date: June 10, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....